DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR
Post-LOEdesloratadine; pseudoephedrine sulfate
ANDAORALTABLET, EXTENDED RELEASE
Approved
Apr 2011
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR (desloratadine; pseudoephedrine sulfate) by Dr. Reddy's Laboratories is long-acting tricyclic histamine antagonist with selective h 1 -receptor histamine antagonist activity. First approved in 2011.
Drug data last refreshed 18h ago
Mechanism of Action
long-acting tricyclic histamine antagonist with selective H 1 -receptor histamine antagonist activity. Receptor binding data indicates that at a concentration of 2 to 3 ng/mL (7 nanomolar), desloratadine shows significant interaction with the human histamine H 1 -receptor. Desloratadine inhibited…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Worked on DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.